Steven Hill
Vorstandsvorsitzender bei NEWHYDROGEN, INC.
Vermögen: - $ am 30.04.2024
Aktive Positionen von Steven Hill
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
NEWHYDROGEN, INC. | Direktor/Vorstandsmitglied | 20.03.2023 | - |
Vorstandsvorsitzender | 15.06.2023 | - | |
Corporate Officer/Principal | 20.03.2023 | 15.06.2023 |
Karriereverlauf von Steven Hill
Ehemalige bekannte Positionen von Steven Hill
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Hill Investments LLC | Corporate Officer/Principal | 01.10.2016 | 01.02.2023 |
RELYPSA INC | Comptroller/Controller/Auditor | 01.12.2015 | 01.10.2021 |
Ausbildung von Steven Hill
Instituto de Empresa SL | Masters Business Admin |
Utah Valley University | Undergraduate Degree |
Statistik
International
Vereinigte Staaten | 5 |
Spanien | 2 |
Operativ
Corporate Officer/Principal | 2 |
Director/Board Member | 1 |
Chief Executive Officer | 1 |
Sektoral
Consumer Services | 3 |
Producer Manufacturing | 2 |
Health Technology | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
NEWHYDROGEN, INC. | Producer Manufacturing |
Private Unternehmen | 2 |
---|---|
Relypsa, Inc.
Relypsa, Inc. Pharmaceuticals: MajorHealth Technology Relypsa, Inc. operates as a bio-pharmaceutical company, which engages in the development and commercialization of late-stage medicines in the iron deficiency, nephrology, and cardio-renal therapeutic areas. It offers Veltassa, a potassium binder approved for the treatment of hyperkalemia. The company was founded by Jerry M. Buysse, Gerrit Klaerner, Michael Burdick, Jay P. Shepard, Detlef F. Albrecht, George Tyson, Sandra I. Coufal and Vic Ciaravino on October 29, 2007 and is headquartered in Redwood City, CA. | Health Technology |
Hill Investments LLC |
- Börse
- Insiders
- Steven Hill
- Erfahrung